Literature DB >> 9238727

Assessment of motor function in people with multiple sclerosis.

L H De Souza1, A Ashburn.   

Abstract

Multiple sclerosis (MS) is a chronic progressive disease of the central nervous system (CNS) which predominantly affects young adults. In order to provide physiotherapy appropriate to the needs of individuals with MS, it is necessary to assess and evaluate the nature and degree of motor and functional deficits. The aim of this research was to develop a physiotherapy assessment which would consistently and objectively evaluate motor function in people with MS. The Motor Club Assessment (MCA), originally developed for use in stroke patients, was identified as exhibiting several features which were consonant with the required criteria. It was therefore modified for use in MS. The Amended MCA (AMCA) was tested for inter-rater agreement, which was found to be good for the lower limb motor section (weighted kappa = 0.80), the upper limb motor section (weighted kappa = 0.90), and the functional activities section (weighted kappa = 0.92). The internal consistency was high for the lower limb section (alpha = 0.97) and the functional activities section (alpha = 0.92), but could not be determined for the upper limb section due to a clear ceiling effect. The study demonstrated that the AMCA is a valid tool for assessment use by physiotherapists in MS patients, and that it has an acceptable level of reliability when used in a clinic setting by physiotherapists suitably experienced in the treatment of neurological patients.

Entities:  

Mesh:

Year:  1996        PMID: 9238727     DOI: 10.1002/pri.6120010206

Source DB:  PubMed          Journal:  Physiother Res Int        ISSN: 1358-2267


  3 in total

1.  A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment.

Authors:  J Craig; C A Young; M Ennis; G Baker; M Boggild
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

2.  Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.

Authors:  Jennifer Freeman; Wendy Hendrie; Louise Jarrett; Annie Hawton; Andrew Barton; Rachel Dennett; Ben Jones; John Zajicek; Siobhan Creanor
Journal:  Lancet Neurol       Date:  2019-08       Impact factor: 44.182

3.  Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.

Authors:  J A Freeman; W Hendrie; S Creanor; L Jarrett; A Barton; C Green; J Marsden; E Rogers; J Zajicek
Journal:  BMC Neurol       Date:  2016-05-05       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.